Lu E et al. conducted a large-scale study that analyzed FH gene variants in a database of 120,061 individuals, finding FH variants in 1.3% of the individuals tested and a higher-than-expected frequency of autosomal dominant HLRCC variants, occurring in about 1 in every 2668 individuals. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.